← Browse by Condition
Medical Condition
young adult
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT06563245 Phase 2, Phase 3
Recruiting
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Enrollment
96 pts
Location
China
Sponsor
Children's Cancer Group, China
NCT07316452
Recruiting
Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis
Enrollment
10,000 pts
Location
China
Sponsor
Fu Wai Hospital, Beijing, Chin...